Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

An Examination of the Role of Transcriptional and Posttranscriptional Regulation in Rhabdomyosarcoma.

Hron AJ, Asakura A.

Stem Cells Int. 2017;2017:2480375. doi: 10.1155/2017/2480375. Epub 2017 May 30. Review.

2.

Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements.

Vicente-García C, Villarejo-Balcells B, Irastorza-Azcárate I, Naranjo S, Acemel RD, Tena JJ, Rigby PWJ, Devos DP, Gómez-Skarmeta JL, Carvajal JJ.

Genome Biol. 2017 Jun 14;18(1):106. doi: 10.1186/s13059-017-1225-z.

3.

Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events.

Crawford Parks TE, Marcellus KA, Langill J, Ravel-Chapuis A, Michaud J, Cowan KN, Côté J, Jasmin BJ.

Sci Rep. 2017 Feb 17;7:42342. doi: 10.1038/srep42342.

4.

FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor.

Milewski D, Pradhan A, Wang X, Cai Y, Le T, Turpin B, Kalinichenko VV, Kalin TV.

Oncogene. 2017 Feb 9;36(6):850-862. doi: 10.1038/onc.2016.254. Epub 2016 Jul 18.

5.

Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation.

Sun M, Huang F, Yu D, Zhang Y, Xu H, Zhang L, Li L, Dong L, Guo L, Wang S.

Cell Death Dis. 2015 Aug 20;6:e1859. doi: 10.1038/cddis.2015.225.

6.

Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma.

Kephart JJ, Tiller RG, Crose LE, Slemmons KK, Chen PH, Hinson AR, Bentley RC, Chi JT, Linardic CM.

Clin Cancer Res. 2015 Nov 1;21(21):4868-80. doi: 10.1158/1078-0432.CCR-14-1797. Epub 2015 Jun 12.

7.

Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma.

Phelps D, Bondra K, Seum S, Chronowski C, Leasure J, Kurmasheva RT, Middleton S, Wang D, Mo X, Houghton PJ.

Pediatr Blood Cancer. 2015 Aug;62(8):1345-52. doi: 10.1002/pbc.25465. Epub 2015 Apr 1.

8.

Modeling of the human alveolar rhabdomyosarcoma Pax3-Foxo1 chromosome translocation in mouse myoblasts using CRISPR-Cas9 nuclease.

Lagutina IV, Valentine V, Picchione F, Harwood F, Valentine MB, Villarejo-Balcells B, Carvajal JJ, Grosveld GC.

PLoS Genet. 2015 Feb 6;11(2):e1004951. doi: 10.1371/journal.pgen.1004951. eCollection 2015.

9.

Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma.

Faggi F, Mitola S, Sorci G, Riuzzi F, Donato R, Codenotti S, Poliani PL, Cominelli M, Vescovi R, Rossi S, Calza S, Colombi M, Penna F, Costelli P, Perini I, Sampaolesi M, Monti E, Fanzani A.

PLoS One. 2014 Jan 10;9(1):e84618. doi: 10.1371/journal.pone.0084618. eCollection 2014.

10.

Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients.

Dumont SN, Araujo DM, Munsell MF, Salganick JA, Dumont AG, Raymond KA, Linassier C, Patel S, Benjamin RS, Trent JC.

Cancer Med. 2013 Aug;2(4):553-63. doi: 10.1002/cam4.92. Epub 2013 Jul 15.

11.

Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Hinson AR, Jones R, Crose LE, Belyea BC, Barr FG, Linardic CM.

Front Oncol. 2013 Jul 17;3:183. doi: 10.3389/fonc.2013.00183. eCollection 2013.

12.

Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.

Hu Q, Yuan Y, Wang C.

PLoS One. 2013 Jun 14;8(6):e68065. doi: 10.1371/journal.pone.0068065. Print 2013.

13.

Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis.

Marshall AD, Grosveld GC.

Skelet Muscle. 2012 Dec 3;2(1):25. doi: 10.1186/2044-5040-2-25.

14.

FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.

Crose LE, Etheridge KT, Chen C, Belyea B, Talbot LJ, Bentley RC, Linardic CM.

Clin Cancer Res. 2012 Jul 15;18(14):3780-90. doi: 10.1158/1078-0432.CCR-10-3063. Epub 2012 May 30.

15.

CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.

Londhe P, Zhu B, Abraham J, Keller C, Davie J.

Int J Cancer. 2012 Aug 15;131(4):E437-48. doi: 10.1002/ijc.26478. Epub 2012 Jan 11.

16.

Clinical utility gene card for: Alveolar rhabdomyosarcoma.

Yu Z, Kelsey A, Alaggio R, Parham D.

Eur J Hum Genet. 2012 Jan;20(1). doi: 10.1038/ejhg.2011.147. Epub 2011 Aug 10. No abstract available.

17.

IRIZIO: a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS).

Picchione F, Pritchard C, Lagutina I, Janke L, Grosveld GC.

Carcinogenesis. 2011 Apr;32(4):452-61. doi: 10.1093/carcin/bgq273. Epub 2010 Dec 22.

18.
19.
20.

Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.

Sebire NJ, Malone M.

J Clin Pathol. 2003 Jun;56(6):412-6. Review.

Supplemental Content

Support Center